Fig. 3
From: Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
Meta-analysis: A SLURP1, B PSCA, C LY6D. OR: odds ratio
Fig. 3 | BMC Urology
From: Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
Meta-analysis: A SLURP1, B PSCA, C LY6D. OR: odds ratio